
[email protected]
Heidi Rehm
Associate Professor of Pathology, Brigham and Women's Hospital and Harvard Medical School; Director, Partners Laboratory for Molecular Medicine
Dr. Heidi L. Rehm, PhD, FACMG is the Director of the Partners Healthcare Laboratory for Molecular Medicine (LMM), the Medical Director of the Broad Institute's Clinical Research Sequencing Platform and Associate Professor of Pathology at Brigham & Women's Hospital and Harvard Medical School. Both clinical labs focus on the rapid translation of new genetic discoveries into clinical tests and bringing novel technologies and software systems into molecular diagnostics to support the integration of genomics into clinical use. Rehm has also been a leader in genomic medicine research, supporting several programs from discovery (Center for Mendelian Genomics), to translation (MedSeq, BabySeq, eMERGE) to building standards to support genomics (ClinGen, GA4GH, ACMG).
Dr. Rehm began building the Laboratory for Molecular Medicine at Partners Personalized Medicine in 2001 after completing her graduate degree in Genetics from Harvard University and her postdoctoral and fellowship training at Harvard Medical School. The lab focuses on the rapid translation of new genetic discoveries into clinical tests and bringing novel technologies and software systems into molecular diagnostics to support the integration of genetics into clinical use. The laboratory has been a leader in translational medicine, launching the first clinical tests for cardiomyopathy and lung cancer treatment. The lab offers whole genome sequencing services for both clinical diagnostics and to support several genomic medicine research projects including the MedSeq and BabySeq projects. She is also involved in defining standards for the use of next generation sequencing in clinical diagnostics and the interpretation of sequence variants through her committee roles at the American College of Medical Genetics. She is also one of several principal investigators of a major NIH-funded effort called ClinGen (Clinical Genome Resource Program) to support broad sharing of genotype and phenotype data and clinical annotations of genetic variants. She also directs the Clinical Molecular Genetics training program at Harvard Medical School and conducts research in hearing loss, Usher syndrome, cardiomyopathy, healthcare IT and genomic medicine.
Related Speakers View all
![]() |
Stephanie Lheureux
Clinician Investigator & Medical Oncologist at Princ...
|
![]() |
Christine Seidman
Thomas W. Smith Professor of Medicine at Harvard Med...
|
![]() |
Aida Habtezion
Chief Medical Officer of Pfizer
|
![]() |
Francisca Mutapi
Global Health Specialist; 2021 TED Fellow; Artist & ...
|
![]() |
Hanneke Schuitemaker
Virologist, Global Head of Viral Vaccine Discovery &...
|
![]() |
Dr. Elizabeth Jaffee
International Leader in Immune Based Therapies for P...
|
![]() |
Victoria Maizes
Executive Director of the Center for Integrative Med...
|
![]() |
Wendy Chung
Physician, Clinical & Molecular Geneticist
|
![]() |
Lisa Cooper
Professor, John Hopkins University of Medicine
|
![]() |
Laurie H. Glimcher
President & CEO of Dana-Farber Cancer Institute; Can...
|
![]() |
Michelle Albert
Immediate-Past President of the AHA; Acclaimed Physi...
|
![]() |
Dr. Vidya Raman-Tangella
Chief Medical Officer at Teladoc Health
|
![]() |
Karen Miga
Genomics Expert; Assistant Research Scientist, Unive...
|
![]() |
Nimmi Ramanujam
Professor of Biomedical Engineering at Duke Universi...
|
![]() |
T.J. Hills
Best-Selling Author, Breast Cancer Prevention & Wome...
|
![]() |
June Tangney
Psychology Professor at George Mason University
|
![]() |
Renaisa Anthony, MD, MPH
Deputy Director of the Center for Reducing Health D...
|
![]() |
Cherie-Ann Nathan
Director of Head and Neck Oncologic Surgery and Rese...
|
![]() |
Lisa Flowers
HPV Specialist
|
![]() |
Adi Utarini
Indonesian Public Health Researcher; Dengue Fever Co...
|